DOI QR코드

DOI QR Code

Preparation of Hydrated Liquid Crystalline Vesicles Containing High Content of Ceramide using a Solubilizer

가용화제를 활용한 세라마이드 고함량의 수화 액정형 베시클 개발

  • Park, Min Seon (Division of Chemistry and Cosmetics, Dongduk Women's University) ;
  • Jin, Byung Suk (Division of Chemistry and Cosmetics, Dongduk Women's University)
  • 박민선 (동덕여자대학교 화학.화장품학부) ;
  • 진병석 (동덕여자대학교 화학.화장품학부)
  • Received : 2021.08.04
  • Accepted : 2021.09.17
  • Published : 2021.10.10

Abstract

Hydrated liquid crystalline vesicles containing a high content of ceramide were prepared by constituting an optimal composition in which ceramides can be mutually self-associated with phospholipid and cholesterol. From the result of manufacturing various vesicles with different component composition, when the edge activator sodium deoxycholate (SDOC) and the solubilizer PEG-60 hydrogenated castor oil (HCO 60) were mixed to form vesicles, the smallest nano-sized particles were produced and the vesicle dispersion solution was weakly acidic and maintained the most stable state. In addition, it was confirmed through polarized light microscopy and thermal analysis that the addition of SDOC and HCO 60 had an effect on the inhibition of crystallinity of lipid components such as ceramide. The stability of the vesicle dispersion solution was maintained without change in appearance and viscosity even after long-term storage at high temperature for eight weeks.

세라마이드와 인지질, 콜레스테롤 등과의 상호적 자가회합이 가능한 최적의 조성을 구성하여 세라마이드 고함량의 수화 액정형 베시클을 제조하였다. 혼합조성을 달리하여 다양한 베시클을 제조한 결과, 에지 액티베이터인 sodium deoxycholate (SDOC)와 가용화제인 PEG-60 hydrogenated castor oil (HCO 60)을 혼합하여 베시클을 만들었을 때, 가장 작은 나노 사이즈의 입자가 만들어지고, 베시클 분산액은 약산성이면서 가장 안정한 상태를 유지하였다. 또한 편광현미경과 열분석을 통해 SDOC와 HCO 60의 첨가가 세라마이드 등 지질 성분의 결정성 억제에 영향을 미치는 것으로 확인되었다. 베시클 분산액은 8주 동안의 고온의 장기 보관에서도 외관 및 점도의 변화없이 안정성이 그대로 유지되었다.

Keywords

References

  1. M. Aoki, K. Ogai, M. Kobayashi, T. Minematsu, T. Nakatani, M. Okuwa, H. Sanada, and J. Sugama, Comparison of ceramide retention in the stratum corneum between dry skin and normal skin using animal model with fluorescent imaging method, Skin Res. Technol. 25, 158-164 (1999). https://doi.org/10.1111/srt.12625
  2. A. L. S. Chang, S .C. Chen, L. Osterberg, S. Brandt, E. C. Von Grote, and M. H. Meckfessel, A daily skincare regimen with a unique ceramide and filaggrin formulation rapidly improves chronic xerosis, pruritus, and quality of life in older adults, Geriatr. Nurs. 39, 24-28 (2018). https://doi.org/10.1016/j.gerinurse.2017.05.002
  3. A. W. Fulmer, and G. J. Kramer, Stratum corneum lipid abnormalities in surfactant induced dry scaly skin, J. Invest. Derm. 86, 598-602 (1986). https://doi.org/10.1111/1523-1747.ep12355351
  4. R. A. Tupker, J. Pinnagoda, P. J. Coenraads, and J. P. Nater, Susceptibility to irritants: role of barrier function, skin dryness and history of atopic dermatitis, Brit. J. of Derm, 123, 199-205 (1990). https://doi.org/10.1111/j.1365-2133.1990.tb01847.x
  5. E. Kahraman, M. Kaykin, H Sahin Bektay, and S. Gungor, Recent advances on topical application of ceramides to restore barrier function of skin, Cosmetics, 6, 52-63 (2019). https://doi.org/10.3390/cosmetics6030052
  6. A. Rawlings, and R. Voegeli, Stratum corneum proteases and dry skin conditions, Cell Tissue Res., 351, 217-235 (2013). https://doi.org/10.1007/s00441-012-1501-x
  7. A. Nakaune-Iijima, A. Sugishima, G. Omura, Kitaoka, H. Kitaoka, T. Tashiro, S. Kageyama, and I. Hatta, Topical treatments with acylceramide dispersions restored stratum corneum lipid lamellar structures in a reconstructed human epidermis model, Chem. Phys. Lipids, 215, 56-62 (2018). https://doi.org/10.1016/j.chemphyslip.2018.05.003
  8. Z. Nemes, and P. M. Steinert, Bricks and mortar of the epidermal barrier, Exp. Mol. Med., 31, 5-19 (1999). https://doi.org/10.1038/emm.1999.2
  9. J. H. Lee, J. B. Lee, and M. S. Park, A cosmetic composition comprising a ceramide containing capsule, KR patent 10-2070557 (2020).
  10. J. H. Hong and E. J. Kim, Macro-capsule containing ceramide and cosmetic composition comprising the same for moisturizing, KR patent 10-1826699 (2018).
  11. Y. J. Kim, J. W. Shim, E. J. An, M. J. Kim, and J. W. Kim, Multi-layered lamellar granule and skin external application composition containing same, KR patent 10-1527580 (2015).
  12. R. Su, L. Yang, Y. Wang, S. Yu, Y. Guo, J. Deng, Q. Zhao, and X. Jin, Formulation, development, and optimization of a novel octyldodecanol-based nanoemulsion for transdermal delivery of ceramide IIIB, Int J Nanomedicine, 12, 5203-5221 (2017). https://doi.org/10.2147/IJN.S139975
  13. T. Gebre-Mariam, J. Wohlrab, E. N. Tessema, and R. H. Neubert, Potential applications of phyto-derived ceramides in improving epidermal barrier function, Ski. Pharmacol. Physiol. 30, 115-138 (2017). https://doi.org/10.1159/000464337
  14. Y. Tokudome, Y. Saito, F. Sato, M. Kikuchi, T. Hinokitani, and K. Goto, Preparation and characterization of ceramide-based liposomes with high fusion activity and high membrane fluidity, Colloids Surf. B Biointerfaces, 73, 92-96 (2009). https://doi.org/10.1016/j.colsurfb.2009.05.002
  15. K. Vavrova, A. Kovacik, and L. Opalka, Ceramides in the skin barrier, Eur. Pharm. J. 64, 1-8 (2017).
  16. Q. Zhang, C. R. Flach, R. Mendelsohn, G. Mao, A. Pappas, M. C. Mack, R. M. Walters, and M. D. Southall, Topically applied ceramide accumulates in skin glyphs, Clin. Cosmet. Investig. Dermatol. 8, 329-337 (2015).
  17. W. G. Cho, K. A. Kim, S. I. Jang, and B. O. Cho, Behaviour of nanoemulsions containing ceramide IIIB and stratum corneum lipids, J. Soc. Cosmet. Sci. Kor., 44(1), 31-37 (2018). https://doi.org/10.15230/SCSK.2018.44.1.31
  18. E. Yilmaz and H. H. Borchert, Design of a phytosphingosine-containing, positively charged nanoemulsion as a colloidal carrier system for dermal application of ceramides, Eur J. Pharm. Biopharm., 60(1), 91-98 (2005). https://doi.org/10.1016/j.ejpb.2004.11.009
  19. M. S. Park, J. W. Choi, S-H, Lee, B. S. JIn, Preparation of hydrated liquid crystalline vesicle using mutual self-association between ceramide and phospholipid, Appl. Chem. Eng., 31(5), 545- 551 (2020). https://doi.org/10.14478/ACE.2020.1062
  20. A. Di Nardo, P. Wertz, A. Giannetti, and S. Seidenari, Ceramide and cholesterol composition of the skin of patients with atopic dermatitis, Acta Derm. Venereol. 78, 27-30 (1998). https://doi.org/10.1080/00015559850135788
  21. S. Y. Lee, Y. M. Lim, and B. S. Jin, Effects of edge activator on the droplet size and skin permeation of hydrated liquid crystalline vesicles, Appl. Chem. Eng. 28(6), 679-684 (2017). https://doi.org/10.14478/ACE.2017.1077
  22. W. Chen, B. Su, H. Xing, Y. Yang, and Q. Ren, Solubilities of cholesterol and desmosterol in binary solvent mixtures of n-hexane+ethanol, Fluid Phase Equilibria, 287(1), 1-6 (2009). https://doi.org/10.1016/j.fluid.2009.08.016
  23. E. Khazanov, A. Priev, J. P. Shillemans and Y. Barenholz, Physicochemical and biological characterization of ceramide-containing liposomes: paving the way to ceramide therapeutic application, Langmuir, 24(13), 6965-6980 (2008). https://doi.org/10.1021/la800207z
  24. A. Hussain, S. Singh, D. Sharma, T. J. Webster, K. Shafaat, and A. Faruk, Elastic liposomes as novel carriers: recent advances in drug delivery, Int J Nanomedicine, 17, 5087-5108 (2017).
  25. M. N. Jones, The surface properties of phospholipid liposome systems and their characterization, Adv. Colloid Interface Sci., 54, 93-128 (1995). https://doi.org/10.1016/0001-8686(94)00223-Y
  26. E. H. Lee, A. Kim, Y. K. Oh, and C. K. Kim, Effect of edge activators on the formation and transfection efficiency of ultradeformable liposomes, Biomaterials, 26(2), 205-210 (2005). https://doi.org/10.1016/j.biomaterials.2004.02.020
  27. S. Vemuri, and C. T. Rhodes, Preparation and characterization of liposomes as therapeutic delivery systems: A review. Pharmaceutica Acta Helvetiae. 70, 95-111(1995). https://doi.org/10.1016/0031-6865(95)00010-7
  28. D. Marsh, and I. Smith, Headgroup conformation and lipid-cholesterol association in phosphatidylcholine vesicles, Biochim. Biophys. Acta, 298, 133-144 (1973). https://doi.org/10.1016/0005-2736(73)90345-3